BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16380509)

  • 1. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a-blockade improves burn-induced cardiac dysfunction.
    Hoesel LM; Niederbichler AD; Schaefer J; Ipaktchi KR; Gao H; Rittirsch D; Pianko MJ; Vogt PM; Sarma JV; Su GL; Arbabi S; Westfall MV; Wang SC; Hemmila MR; Ward PA
    J Immunol; 2007 Jun; 178(12):7902-10. PubMed ID: 17548628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
    Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
    FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement dependency of cardiomyocyte release of mediators during sepsis.
    Atefi G; Zetoune FS; Herron TJ; Jalife J; Bosmann M; Al-Aref R; Sarma JV; Ward PA
    FASEB J; 2011 Jul; 25(7):2500-8. PubMed ID: 21478262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a functional role of the second C5a receptor C5L2.
    Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
    FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complement C5a and histones in septic cardiomyopathy.
    Fattahi F; Frydrych LM; Bian G; Kalbitz M; Herron TJ; Malan EA; Delano MJ; Ward PA
    Mol Immunol; 2018 Oct; 102():32-41. PubMed ID: 29914696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement and sepsis-induced heart dysfunction.
    Fattahi F; Ward PA
    Mol Immunol; 2017 Apr; 84():57-64. PubMed ID: 27931779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a receptor and thymocyte apoptosis in sepsis.
    Riedemann NC; Guo RF; Laudes IJ; Keller K; Sarma VJ; Padgaonkar V; Zetoune FS; Ward PA
    FASEB J; 2002 Jun; 16(8):887-8. PubMed ID: 12039868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.
    Kalbitz M; Fattahi F; Grailer JJ; Jajou L; Malan EA; Zetoune FS; Huber-Lang M; Russell MW; Ward PA
    FASEB J; 2016 Dec; 30(12):3997-4006. PubMed ID: 27543123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
    Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
    J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-complement strategies in experimental sepsis.
    Ward PA; Riedemann NC; Guo RF; Huber-Lang M; Sarma JV; Zetoune FS
    Scand J Infect Dis; 2003; 35(9):601-3. PubMed ID: 14620141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
    Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
    FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The harmful role of c5a on innate immunity in sepsis.
    Ward PA
    J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
    Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
    J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a, a therapeutic target in sepsis.
    Guo RF; Ward PA
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):57-65. PubMed ID: 18221134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis, apoptosis and complement.
    Ward PA
    Biochem Pharmacol; 2008 Dec; 76(11):1383-8. PubMed ID: 18848819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased C5a receptor expression in sepsis.
    Riedemann NC; Guo RF; Neff TA; Laudes IJ; Keller KA; Sarma VJ; Markiewski MM; Mastellos D; Strey CW; Pierson CL; Lambris JD; Zetoune FS; Ward PA
    J Clin Invest; 2002 Jul; 110(1):101-8. PubMed ID: 12093893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the complement in experimental sepsis.
    Ward PA
    J Leukoc Biol; 2008 Mar; 83(3):467-70. PubMed ID: 17875813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of innate immunity by C5aR antagonist in septic mice.
    Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
    FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.